Technical Analysis for FULC - Fulcrum Therapeutics, Inc.

Grade Last Price % Change Price Change
F 3.54 3.21% 0.11
FULC closed up 3.31 percent on Wednesday, November 6, 2024, on 86 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 3.21%
Pocket Pivot Bullish Swing Setup 3.21%
Doji - Bearish? Reversal 3.21%
Earnings Movers Other 3.21%
Gapped Up Strength 3.21%
Up 3 Days in a Row Strength 3.21%
Up 4 Days in a Row Strength 3.21%
Pocket Pivot Bullish Swing Setup 6.63%
Earnings Movers Other 6.63%
Inside Day Range Contraction 6.63%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 3 hours ago
Up 3% about 3 hours ago
Up 2% about 3 hours ago
Up 1% about 3 hours ago
Possible Pocket Pivot about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Disease Disability Disorders Dystrophy Muscular Dystrophy Progressive Hemoglobin Infancy Sickle Cell Disease Thalassemia Facioscapulohumeral Muscular Dystrophy

Is FULC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.7
52 Week Low 2.865
Average Volume 1,851,534
200-Day Moving Average 7.40
50-Day Moving Average 4.46
20-Day Moving Average 3.37
10-Day Moving Average 3.25
Average True Range 0.24
RSI (14) 42.86
ADX 22.72
+DI 20.56
-DI 23.63
Chandelier Exit (Long, 3 ATRs) 3.03
Chandelier Exit (Short, 3 ATRs) 3.85
Upper Bollinger Bands 3.68
Lower Bollinger Band 3.06
Percent B (%b) 0.6
BandWidth 18.46
MACD Line -0.29
MACD Signal Line -0.40
MACD Histogram 0.1032
Fundamentals Value
Market Cap 212.05 Million
Num Shares 61.8 Million
EPS -1.66
Price-to-Earnings (P/E) Ratio -2.07
Price-to-Sales 208.91
Price-to-Book 2.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.78
Resistance 3 (R3) 3.75 3.61 3.72
Resistance 2 (R2) 3.61 3.53 3.63 3.70
Resistance 1 (R1) 3.52 3.47 3.55 3.55 3.68
Pivot Point 3.38 3.38 3.40 3.40 3.38
Support 1 (S1) 3.29 3.30 3.32 3.32 3.18
Support 2 (S2) 3.15 3.24 3.17 3.16
Support 3 (S3) 3.06 3.15 3.14
Support 4 (S4) 3.09